Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Brickell org - The Untold Story

The death of the 99: Why we’ll pay £5 for gelato but resent £3.50 for Mr Whippy

LET’S UNPACK THAT: As artisan gelaterias charge £5 a scoop without protest, the humble soft serve is melting in the heat of modern costs and childhood expectations. Hannah Twiggs asks why Mr Whippy is still expected to live on pocket money

The Independent UK · Jul 30

‘Out of this world’: the best supermarket chocolate ice-cream, tasted and rated

Who makes the smoothest, creamiest, chocolatiest tub? We have the inside scoop for you

The Guardian - UK · Jul 25

Cheese, cider, cycling: a tasty tour of the West Country

Following the Somerset Food Trail by e-bike offers the chance to meet growers and makers, enjoy beautiful scenery, and sample delicious local produce

The Guardian - UK · Jul 7, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga · May 4, 2022

Brickell Biotech Shares Surge After Offloading Late-Stage Asset To Australia-Based Firm

Brickell Biotech Inc (NASDAQ:BBI) agreed to sell sofpironium bromide rights to Australia-based Botanix Pharmaceuticals Limited. Brickell will receive upfront and potential near-term regulatory milestone payments over the next 18 months of up to $9 million. Brickell also is eligible to receive additional milestone payments of up to $168 million and tiered earn-out payments ranging from high-single…

Benzinga · May 4, 2022

Brickell Biotech, Carna Biosciences Ink Licensing Pact For STING inhibitors

Brickell Biotech Inc (NASDAQ: BBI) has

Benzinga · Feb 2, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.